Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic Subjects

NCT00903409 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Simvastatin + Lovaza® (omega-3-acid ethyl esters)

Sponsor

GlaxoSmithKline